放射性藥品
- 专利权人:
- BAYER AS
- 发明人:
- CUTHBERTSON, ALAN,卡斯柏森 亚伦,卡斯柏森 亞倫,卡斯柏森 亚伦,卡斯柏森 亞倫
- 申请号:
- TW107106066
- 公开号:
- TW201840341A
- 申请日:
- 2018.02.23
- 申请国别(地区):
- TW
- 年份:
- 2018
- 代理人:
- 摘要:
- The present invention provides a method of combination therapy comprising administration of a tissue-targeting radiopharmaceutical and a DNA-repair inhibitor. The method may be used in the treatment of hyperplastic or neoplastic disease, such as a carcinoma, sarcoma, myeloma, leukemia, lymphoma or mixed type cancer.本發明提供一種組合療法之方法,其包含投與組織靶向放射性藥品及DNA修復抑制劑。該方法可用於治療增生性或贅生性疾病,諸如癌瘤、肉瘤、骨髓瘤、白血病、淋巴瘤或混合型癌症。
- 来源网站:
- 中国工程科技知识中心
相关发明人
相关专利
- FUNCTIONAL ORGANIC MATERIAL FOR INHIBITING PLANT DISEASE INJURY
- Fumarate-CO-releasing molecule hybrids, their use in the treatment of inflammatory diseases or cardiovascular diseases and methods for their preparation
- Cholesteryl ester transfer protein (CETP) inhibitor for use in the treatment or prevention of cardiovascular disease and pharmaceutical composition containing the inhibitor
- CO-fumarate release molecule hybrids, their use in the treatment of inflammatory or cardiovascular diseases and their preparation procedure
- HIGHLY EFFICIENT NRF2 ACTIVATORS-CO-RELEASING MOLECULE HYBRIDS, THEIR USE IN THE TREATMENT OF INFLAMMATORY OR CARDIOVASCULAR DISEASES AND THEIR PROCESS OF PREPARATION